Catalyst Funds Management Pty LTD Artivion, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Artivion, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 2,200 shares of AORT stock, worth $59,070. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,200Holding current value
$59,070% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
175Shares Held
35.9MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$178 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$75.3 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$75 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$73.7 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$65.8 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.08B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...